Volgen
Jonathan Adachi
Jonathan Adachi
Professor of Medicine, McMaster University
Geverifieerd e-mailadres voor mcmaster.ca
Titel
Geciteerd door
Geciteerd door
Jaar
Zoledronic acid and clinical fractures and mortality after hip fracture
KW Lyles, CS Colón-Emeric, JS Magaziner, JD Adachi, CF Pieper, ...
New England Journal of Medicine 357 (18), 1799-1809, 2007
24952007
Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis
KG Saag, R Emkey, TJ Schnitzer, JP Brown, F Hawkins, S Goemaere, ...
New England Journal of Medicine 339 (5), 292-299, 1998
15821998
Romosozumab treatment in postmenopausal women with osteoporosis
F Cosman, DB Crittenden, JD Adachi, N Binkley, E Czerwinski, S Ferrari, ...
New England Journal of Medicine 375 (16), 1532-1543, 2016
14252016
Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women
GA Wells, SC Hsieh, C Zheng, J Peterson, W Liu, SE Kelly, P Tugwell
Cochrane database of systematic reviews, 2022
1025*2022
Canadian normative data for the SF-36 health survey
WM Hopman, T Towheed, T Anastassiades, A Tenenhouse, S Poliquin, ...
Cmaj 163 (3), 265-271, 2000
9662000
Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis
JD Adachi, WG Bensen, J Brown, D Hanley, A Hodsman, R Josse, ...
New England Journal of Medicine 337 (6), 382-388, 1997
9411997
Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial
PD Delmas, KE Ensrud, JD Adachi, KD Harper, S Sarkar, C Gennari, ...
The Journal of Clinical Endocrinology & Metabolism 87 (8), 3609-3617, 2002
7722002
Two‐year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double‐blind, placebo‐controlled extension trial
JD Adachi, KG Saag, PD Delmas, UA Liberman, RD Emkey, E Seeman, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2001
7162001
Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial
PD Delmas, HK Genant, GG Crans, JL Stock, M Wong, E Siris, JD Adachi
Bone 33 (4), 522-532, 2003
6562003
Obesity is not protective against fracture in postmenopausal women: GLOW
JE Compston, NB Watts, R Chapurlat, C Cooper, S Boonen, S Greenspan, ...
The American journal of medicine 124 (11), 1043-1050, 2011
6192011
II. Meta-analysis of alendronate for the treatment of postmenopausal women
ANN Cranney, G Wells, A Willan, L Griffith, N Zytaruk, V Robinson, ...
Endocrine Reviews 23 (4), 508-516, 2002
5512002
Effect of selective serotonin reuptake inhibitors on the risk of fracture
JB Richards, A Papaioannou, JD Adachi, L Joseph, HE Whitson, JC Prior, ...
Archives of internal medicine 167 (2), 188-194, 2007
5452007
Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study
G Ioannidis, A Papaioannou, WM Hopman, N Akhtar-Danesh, ...
Cmaj 181 (5), 265-271, 2009
5412009
Economic implications of hip fracture: health service use, institutional care and cost in Canada
ME Wiktorowicz, R Goeree, A Papaioannou, JD Adachi, ...
Osteoporosis international 12, 271-278, 2001
5412001
III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis
A Cranney, P Tugwell, J Adachi, B Weaver, N Zytaruk, A Papaioannou, ...
Endocrine Reviews 23 (4), 517-523, 2002
520*2002
Quality of life issues in women with vertebral fractures due to osteoporosis
DJ Cook, GH Guyatt, JD Adachi, J Clifton, LE Griffith, RS Epstein, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 1993
4431993
A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis
S Lekamwasam, JD Adachi, D Agnusdei, J Bilezikian, S Boonen, ...
Osteoporosis International 23, 2257-2276, 2012
4402012
The n-of-1 randomized controlled trial: clinical usefulness: our three-year experience
GH Guyatt, JL Keller, R Jaeschke, D Rosenbloom, JD Adachi, ...
Annals of internal medicine 112 (4), 293-299, 1990
4281990
The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis.
JP Brown, DL Kendler, MR McClung, RD Emkey, JD Adachi, ...
Calcified Tissue International 71 (2), 2002
4112002
Frailty and sarcopenia: definitions and outcome parameters
C Cooper, W Dere, W Evans, JA Kanis, R Rizzoli, AA Sayer, CC Sieber, ...
Osteoporosis International 23, 1839-1848, 2012
4042012
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20